MedPath

ALVESCO

ALVESCO

Approved
DIN Number

02285614

Drug Class

Human

Market Date

Sep 27, 2006

Company
HC

Covis Pharma GmbH

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02285614
AIG Number0151669002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA08 CICLESONIDE
Product Specifications
Dosage FormAerosol, Metered Dose
Route of AdministrationInhalation
AHFS Classification68:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CICLESONIDEActive
Strength: 200 MCG / ACT
Monograph: CICLESONIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.